1. Home
  2. YJ vs GNPX Comparison

YJ vs GNPX Comparison

Compare YJ & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YJ
  • GNPX
  • Stock Information
  • Founded
  • YJ 2015
  • GNPX 2009
  • Country
  • YJ China
  • GNPX United States
  • Employees
  • YJ N/A
  • GNPX N/A
  • Industry
  • YJ Other Specialty Stores
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • YJ Consumer Discretionary
  • GNPX Health Care
  • Exchange
  • YJ Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • YJ 9.3M
  • GNPX 10.8M
  • IPO Year
  • YJ 2019
  • GNPX 2018
  • Fundamental
  • Price
  • YJ $1.71
  • GNPX $4.22
  • Analyst Decision
  • YJ
  • GNPX
  • Analyst Count
  • YJ 0
  • GNPX 0
  • Target Price
  • YJ N/A
  • GNPX N/A
  • AVG Volume (30 Days)
  • YJ 8.4K
  • GNPX 1.8M
  • Earning Date
  • YJ 11-25-2025
  • GNPX 11-14-2025
  • Dividend Yield
  • YJ N/A
  • GNPX N/A
  • EPS Growth
  • YJ N/A
  • GNPX N/A
  • EPS
  • YJ N/A
  • GNPX N/A
  • Revenue
  • YJ $47,760,127.00
  • GNPX N/A
  • Revenue This Year
  • YJ N/A
  • GNPX N/A
  • Revenue Next Year
  • YJ N/A
  • GNPX N/A
  • P/E Ratio
  • YJ N/A
  • GNPX N/A
  • Revenue Growth
  • YJ N/A
  • GNPX N/A
  • 52 Week Low
  • YJ $1.37
  • GNPX $4.17
  • 52 Week High
  • YJ $2.67
  • GNPX $117.50
  • Technical
  • Relative Strength Index (RSI)
  • YJ 35.76
  • GNPX 49.65
  • Support Level
  • YJ $1.80
  • GNPX $7.71
  • Resistance Level
  • YJ $1.90
  • GNPX $6.30
  • Average True Range (ATR)
  • YJ 0.05
  • GNPX 1.50
  • MACD
  • YJ -0.03
  • GNPX -0.43
  • Stochastic Oscillator
  • YJ 3.57
  • GNPX 0.57

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in the PRC.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: